We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a first-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology.
We will additionally build a state-of-the art and not-for-profit drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe.
Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication. Blockchain can also manage complex data rights and allow finegrained access using smart contracts.
With SHIVOM everybody will be able to get their genome sequenced and stored, and our ecosystem will ofer an open web-marketplace for other
providers to add their apps and services, alongside genomic data analytics and personalized medicine. Solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
Ethereum ERC20 standard token.
Q1 2017
Q2-Q3 2017
Q3-Q4 2017
Q1 2018
Q1-Q2 2018
Q1-Q2 2018
Q2 2018
Q2 2018
Q2 2018
Q2-Q3 2018
Q3 2018
Q3 2018
Q3 2018
Q3 2018
Q3 2018
Q3-Q4 2018
Q4 2018
Q4 2018/Q1 2019
Q1 2019
Verified 58%
Attention. There is a risk that unverified members are not actually members of the team
SHIVOM is a decentralized block chain platform where people can get their genome sequenced and stored hence enabling the establishment of a highly scalable and fully integrated health care vertical.
PROS:
CONS:
SUGGESTIONS:
Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions.
In conclusion for this stage, there is not enough information regarding the Shivom project. There is little information on the part of their operations and supposed partnerships or advisors. As such, I would not recommend on putting your investment in such a project.
Strengths: signed partnerships; very strong team and world-renowned advisors. Thorough market research and clear vision of the market, business model is presented in detailed way.
Weaknesses: no financial plan/projection, no competitor analysis, no marketing plan. The product is technically advanced, this may require additional funds.
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.